Casi Pharms Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for CASI PHARMS INC, and what generic and branded alternatives to CASI PHARMS INC drugs are available?
CASI PHARMS INC has seven approved drugs.
Drugs and US Patents for Casi Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Casi Pharms Inc | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | TABLET;ORAL | 076280-001 | Nov 26, 2002 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Casi Pharms Inc | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | TABLET;ORAL | 077517-001 | Jun 25, 2007 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Casi Pharms Inc | CILOSTAZOL | cilostazol | TABLET;ORAL | 077310-001 | Nov 8, 2005 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Casi Pharms Inc | TENOFOVIR DISOPROXIL FUMARATE | tenofovir disoproxil fumarate | TABLET;ORAL | 209550-001 | Feb 26, 2018 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.